Mostrando 3 resultados de: 3
Subtipo de publicación
Article(3)
Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study data
ArticleAbstract: Background Hypertension is considered the most important risk factor for cardiovascular diseases, buPalabras claves:Autores:Agapay D., Alhabib K.F., Aliberti A., Aoucheva N., Attaei M.W., Auger D., Avezum A.J., Azad A.K., Bahonar A., Casaccia G., Casanova A., Cherry H.M., Chin S.L., Choudhury T., Chow C.K., Dagenais G.R., Dayal L., Dehghan M., Dejesus J., Devanath A., DIaz R., Elsheikh W., Gupta R., Hall K., Haque R., Hari D., Hassan I., Heldman L., Hu W., Hussain F., Igumbor E.U., Islam S., Joseph P.G., Kandy N., Kaur M., Kay I., Keneth J., Keys J., Khan M.U., Khatib R., Kruger L., Kutty R., Lanas F.T., Lear S.A., Leong D.P., Lewis B.S., Lewis G., Lindeman J., Linetsky B., Mackie P., Maini Cuneo J.M., Mannan A., Marcilio C.S., Mattos A.C., Mckee M., McQueen M.J., Mente A., Milazzo E., Mohan V., Mushtaha M., Oguz A., Oliveira G.B.F., Orlandini A., O’Donnell M., Parvin S., PATRICIO LOPEZ -JARAMILLO, Poirier P., Rabbani K.A., Rahman O., Ramacham S., Ramasundarahettige C., Ramezani E., Rangarajan S., Reyes A., Rimac J., Rosengren A., Shahrook S., Shifaly F., Sintaha M., Smyth A., Solano R., Swallow J., Szuba A., Talukdar A.T., Teo K.K., Tongana T., Tooheen R.B., Toscanelli S., Trottier M., Trottier S., Turbide G., Wang X., Wong G.W.K., Yusoff K., Yusuf R., Yusuf S., Yusufali A.M., Zaki A., Zhang B., Zhang M.Fuentes:googlescopusFruit, vegetable, and legume intake, and cardiovascular disease and deaths in 18 countries (PURE): a prospective cohort study
ArticleAbstract: Background The association between intake of fruits, vegetables, and legumes with cardiovascular disPalabras claves:Autores:Agapay D., Altuntas Y., Anand S.S., Auger D., Avezum A.J., Azad A.K., Bangdiwala S.I., Bo H., Bonneville N., Casaccia G., Cayer M., Cherry H.M., Chifamba J., Choudhury T., Chunming C., Corber E., Cuneo J.M., Dagenais G.R., De Bluts A.L.B., de Jong V., Dehghan M., Dejesus J., DIaz R., Elsheikh W., Fodor G.J., Gasevic D., Gupta R., Haque R., Hassan I., Heldman L., Hongye Z., Iqbal R., Jian B., Kay I., Khan M.U., Khatib R., Kutty V.R., Lana F., Lanas F., Lear S.A., Li W., Linetsky B., Liu J., Liu L., Liu X., Mannan A., Marcilio C.S., Martinez S., Mattos A.C., Mente A., Miller V., Mohammadifard N., Mohan V., Noorhassim I., Oliveira G.B.F., Oliveros M.J., Orlandini A., Parvin S., PATRICIO LOPEZ -JARAMILLO, Peer N., Pipe A., Poirier P., Proulx M.C., Rabbani K.A., Rahman O., Ramezani E., Rangarajan S., Rimac J., Rosengren A., Schutte A.E., Seron P., Shane A., Sintaha M., Solano R., Swaminathan S., Talukdar A.T., Teo K.K., Tongana T., Tooheen R.B., Toscanelli S., Trottier S., Turbide G., Valdebenito A., Vukmirovich I., Wei L., Wenhua Z., Wentzel-Viljoen E., Wielgosz A., Xiaohong C., Xingyu W., Xiuwen Z., Xuan J., Yi S., Yin L., Yusoff K., Yusuf R., Yusuf S., Yusufali A.M., Zatońska K., Zhang X.Fuentes:googlescopusInequalities in the use of secondary prevention of cardiovascular disease by socioeconomic status: evidence from the PURE observational study
ArticleAbstract: Background: There is little evidence on the use of secondary prevention medicines for cardiovascularPalabras claves:Autores:Alhabib K.F., Avezum A.J., Bai X., Chifamba J., Chow C.K., Corsi D.J., Dagenais G.R., Dans A.M., DIaz R., Erbakan A.N., Iqbal R., Kelishadi R., Khatib R., Lanas F., Lear S.A., Li W., Liu J., Mckee M., Mohan V., Monsef N., Mony P.K., Murphy A., Noorhassim I., O'Donnell O., Palafox B., PATRICIO LOPEZ -JARAMILLO, Perel P., Puoane T., Rangarajan S., Rosengren A., Schutte A.E., Sintaha M., Stuckler D., Teo K.K., Wielgosz A., Yeates K.E., Yin L., Yusoff K., Yusuf S., Zatońska K.Fuentes:googlescopus